Close Menu

In PLoS One this week, researchers from six US institutions report the results of their genome-wide association study that identifies GPC5 as a novel genetic locus that is protective against sudden cardiac arrest. Using a case-control design with participants from the Oregon Sudden Unexpected Death Study, and, while no SNPs identified reached genome-wide significance, the minor allele of GPC5 showed an association with a lower risk of SCA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.